Organon (OGN) EBT (2020 - 2026)

Organon has reported EBT for 7 years, with the latest figure at $183.0 million in Q2 2026.

• On a quarterly basis, EBT fell 20.09% year-over-year to $183.0 million in Q2 2026; TTM through Jun 2026 was $491.0 million, a 26.28% decrease from a year earlier, with the FY2025 full-year figure at $425.0 million, down 47.34% from the prior year.
• EBT was $183.0 million for Q2 2026 at Organon, down from $213.0 million in the prior quarter.
• The five-year high for EBT was $562.0 million in Q4 2022, with the low at -$148.0 million in Q4 2025.
• Average EBT over 5 years is $215.2 million, with a median of $232.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: EBT surged 158.75% in 2024, then tumbled 214.73% in 2025.
• Over 5 years, EBT stood at $562.0 million in 2022, then tumbled by 81.49% to $104.0 million in 2023, then climbed by 24.04% to $129.0 million in 2024, then sank by 214.73% to -$148.0 million in 2025, then jumped by 223.65% to $183.0 million in 2026.
• The last three EBT figures came in at $183.0 million (Q2 2026), $213.0 million (Q1 2026), and -$148.0 million (Q4 2025), per Business Quant data.